GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Oncozenge ONCOZ.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

3.30

+4.43%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 2.7m

FY2020FY2025

Net income

−SEK 15.9m

FY2020FY2025

Free cash flow

−SEK 26.1m

FY2020FY2025

Shareholders' equity

−SEK 587,000

FY2020FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
RevenueSEK 2.7mSEK 1,000SEK 3,000———
Research and developmentSEK 11.0mSEK 1.7mSEK 7.4mSEK 37.6mSEK 216,000—
Operating income−SEK 15.9m−SEK 8.7m−SEK 15.9m−SEK 43.6m−SEK 4.9m−SEK 801,000
Net income−SEK 15.9m−SEK 8.7m−SEK 15.9m−SEK 46.6m−SEK 3.9m−SEK 636,000
Diluted earnings per share-1.26-0.74-1.36-3.98-0.33-0.05

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Total assetsSEK 15.3mSEK 11.4mSEK 20.3mSEK 36.9mSEK 85.2mSEK 38.3m
Cash and short-term investmentsSEK 3.7mSEK 3.9mSEK 12.6mSEK 29.1mSEK 51.2mSEK 10.0m
Total liabilitiesSEK 15.9mSEK 1.5mSEK 1.7mSEK 2.9mSEK 4.9mSEK 9.0m
DebtSEK 7.5m—————
Shareholders' equity−SEK 587,000SEK 9.9mSEK 18.6mSEK 34.0mSEK 80.3mSEK 29.3m
Shares outstanding13m12m12m12m12m14m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations−SEK 13.1m−SEK 8.8m−SEK 17.1m−SEK 22.1m−SEK 4.8m−SEK 1,000
Capital spending−SEK 13.1m———−SEK 5.4m—
Free cash flow−SEK 26.1m−SEK 8.8m−SEK 17.1m−SEK 22.1m−SEK 10.1m−SEK 1,000

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 5.8m———SEK 117,000SEK 2.7m——
Operating income−SEK 5.4m−SEK 6.8m−SEK 9.7m−SEK 3.5m−SEK 2.6mSEK 44,000−SEK 2.5m−SEK 1.8m
Net income−SEK 5.7m−SEK 7.1m−SEK 9.9m−SEK 3.5m−SEK 2.6mSEK 44,000−SEK 2.5m−SEK 1.8m
Diluted earnings per share-0.40-0.51-0.78-0.28-0.210.00-0.21-0.15
Cash from operations−SEK 2.0m−SEK 10.0m−SEK 7.0m−SEK 3.0m—−SEK 2.0m−SEK 1.0m−SEK 1.0m
Capital spending——−SEK 13.0m—————
Free cash flow——−SEK 20.0m—————
Total assetsSEK 11.7mSEK 11.8mSEK 15.3mSEK 19.8mSEK 15.3mSEK 11.7mSEK 11.4mSEK 13.7m
Cash and short-term investmentsSEK 749,000SEK 935,000SEK 3.7mSEK 11.6mSEK 1.6mSEK 1.3mSEK 3.9mSEK 5.8m
DebtSEK 7.5mSEK 7.5mSEK 7.5m—————
Shareholders' equity−SEK 5.3mSEK 358,000−SEK 587,000SEK 9.3mSEK 12.8mSEK 10.0mSEK 9.9mSEK 12.5m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-28.6%81.7%—
Net income-30.1%90.5%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-921.4%———
Net margin-924.1%———

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-5.4-5.1-0.9-0.3-2.5
Price to sales32.1————

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.